Next 10 |
home / stock / czmwy / czmwy news
2024-03-21 09:55:58 ET More on Carl Zeiss Meditec AG Carl Zeiss: We've Seen Outperformance, But I See More Upside Potential Historical earnings data for Carl Zeiss Meditec AG Dividend scorecard for Carl Zeiss Meditec AG Financial information for Carl Zeiss Me...
2024-01-26 02:41:50 ET Summary Carl Zeiss Meditec has seen a significant increase in stock performance, up over 29% in less than 3 months. The company has shown strong top-line growth but a decline in EBIT and EBIT margin. Challenges include a decline in volume, unfavorable sa...
2023-12-19 13:00:57 ET More on Carl Zeiss Meditec AG, Carl Zeiss Meditec AG, etc. Carl Zeiss Meditec: Premiums Are Proven To Be Dicey In This Market Historical earnings data for Carl Zeiss Meditec AG Dividend scorecard for Carl Zeiss Meditec AG Financial info...
2023-10-24 03:32:23 ET Summary Carl Zeiss Meditec has seen a decline in its stock price, along with other high-valued companies, due to the commoditization of premium stocks. The company has impressive products, high gross margins, and strong financial performance compared to its ...
2023-08-08 05:13:37 ET Summary Carl Zeiss Meditech is a subsidiary of Carl Zeiss AG and manufactures tools for eye examination and medical lasers. The company has a strong financial performance with high gross and net margins. Despite being heavily focused on the German market...
2023-05-22 09:38:49 ET Summary Carl Zeiss falls short of expectations in H1, with its bottom line suffering steep declines in the face of several headwinds. While some of the H1 detractors are transitory, the lowered guidance points to structural headwinds as well, particularly on...
Summary Brent Saunders led Bausch + Lomb Corporation when it was sold to Valeant Pharmaceuticals. He later led and sold competitor Allergan to AbbVie. Brent Saunders likely signed on as CEO with the expectation of operating Bausch + Lomb Corporation as a fully standalone company. ...
Summary Carl Zeiss Meditec recorded strong order growth of 36% YoY in Q3 FY9/2022 results, highlighting strong underlying demand. Operating margins look stable at 20%, driven by an improving sales mix despite ongoing investment in R&D and marketing activities. The shares h...
Carl Zeiss Meditec AG (CZMWF) Q3 2022 Earnings Conference Call August 05, 2022 03:30 AM ET Company Participants Sebastian Frericks - Head of Investor Relations Markus Weber - Chief Executive Officer Justus Wehmer - Chief Financial Officer Conference Call Pa...
The following slide deck was published by Carl Zeiss Meditec AG in conjunction with their 2022 Q3 earnings call. For further details see: Carl Zeiss Meditec AG 2022 Q3 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Carl Zeiss Meditec AG ADR Company Name:
CZMWY Stock Symbol:
OTCMKTS Market:
Innovation and digitalization have been in focus among ophthalmology majors. The ophthalmology market is attractive, at an estimated $34 billion, w...